The Angels' Forum

The Angels' Forum LLC is a venture capital firm based in Redwood City, California, that focuses on seed and early-stage investments in the San Francisco Bay Area and Silicon Valley. Founded in 1997 by Carol Sands, the firm specializes in disruptive technologies, targeting sectors such as software, information technology, life sciences, and consumer products. The Angels' Forum typically invests between $0.1 million and $1 million in companies that are often seeking Series A financing, with the potential for follow-on investments in subsequent rounds. The firm has a preference for companies headquartered within 50 miles of Mountain View and generally collaborates with other venture funds for co-investments. While it does not typically take a board seat, it may seek observation rights in its portfolio companies. The firm invests in a select number of companies each year, focusing on leveraging its expertise in technology and life sciences to support innovative startups.

Klaus Hambuechen

Partner and Investor

41 past transactions

VIDA

Series C in 2020
VIDA is a lung health company focused on modernizing respiratory care through artificial intelligence and advanced data analytics. It empowers healthcare organizations and physicians to enhance patient outcomes, improve care coordination, and drive efficiencies. VIDA's comprehensive software solutions, which are FDA cleared and CE-marked, assist in managing patients with chronic obstructive pulmonary disease, interstitial lung disease, lung cancer, and COVID-19. The company also provides a full suite of clinical trial services, including advanced quantitative image analysis, to strengthen trial data and site quality, as well as subject screening. With a commitment to proven quality and clinical leadership, VIDA aims to accelerate the delivery of new therapies to patients.

Halio

Series C in 2017
Halio specializes in advanced smart-tinting glass that adapts to changing light conditions, enhancing architectural design and efficiency. Its innovative technology allows the glass to transition from clear to tinted or dark in seconds, providing shade, glare relief, and privacy as needed. Unlike traditional electrochromic glass, Halio's product offers uniform tinting without undesirable hues, achieving a natural glass appearance in various neutral shades. The company also provides sophisticated software and hardware controls that integrate seamlessly with building management systems. Halio’s manufacturing process ensures high yields akin to the flat panel display industry, allowing for reliable and timely deliveries worldwide. This transformative glass not only improves the comfort and aesthetics of buildings but also fosters a deeper connection between indoor environments and the outside world.

OneMob

Venture Round in 2017
OneMob, Inc. is a communications platform based in San Francisco, California, that specializes in personalizing customer interactions to enhance sales and marketing efforts. The company provides a video and voice messaging platform that enables sales, customer success, and support representatives to create, upload, and distribute personalized and trackable video and voice messages. OneMob's innovative solutions include microsites that consolidate personalized content, digital sales rooms for improved buyer collaboration, and video prospecting tools. The platform features AI-powered capabilities for video creation and writing assistance, allowing users to produce professional communications efficiently. With integrations for popular CRM systems and robust email campaign functionalities, OneMob empowers businesses to scale their outreach while maintaining a personal touch. Trusted by notable enterprise clients, OneMob has received multiple accolades, including recognition as a Gartner Cool Vendor and a Gold Stevie Award Winner. The company is recognized for its rapid growth and commitment to driving measurable impact in sales and marketing through advanced technology.

Kiana Analytics

Series A in 2017
Kiana Analytics, Inc. specializes in cloud-based device detection and customer analytics software aimed at enhancing operations and proximity marketing. Its flagship product, Presence Analytics, empowers retailers to improve store performance and sales conversion by analyzing customer traffic and behaviors prior to the point of sale. The technology utilizes Wi-Fi fingerprints from customer smartphones to detect presence and track movements, enabling predictive analysis of store traffic. Kiana Analytics serves a diverse clientele, including retailers, shopping centers, restaurant chains, event venues, and various businesses globally. Founded in 2013 and headquartered in Sunnyvale, California, the company leverages its expertise in Big Data analytics to deliver deep insights into customer behavior while prioritizing privacy and operational efficiency.

Glue Networks

Venture Round in 2017
Glue Networks specializes in providing an enterprise-grade cloud networking service. Glue Virtual Office is available to enterprise customers through partnerships between Glue Networks and top service providers and value-added resellers. It was founded in 2007 and headquartered in Sacramento, California.

Hospi

Venture Round in 2017
Hospi Corporation specializes in developing and manufacturing medical devices aimed at improving the quality of life for patients with serious or terminal illnesses, as well as assisting their caregivers. The company is best known for the Macy Catheter, a patented device designed to facilitate discreet rectal administration of liquids and medications, which is especially beneficial for patients who have difficulty swallowing. This innovative catheter, co-developed by a hospice nurse, addresses an important need in hospice and palliative care settings. Hospi also offers The Liquipill system for preparing medication suspensions from pills, a bedside care kit for using the Macy Catheter, and a valved port for urinary catheter irrigation. Founded in 2012, the company is based in Newark, California, and focuses on enhancing patient comfort and caregiver efficiency while reducing costs in healthcare delivery.

Chimera Bioengineering

Venture Round in 2016
Chimera Bioengineering focuses on developing gene therapeutics that aim to reprogram the immune system for cancer treatment. Their innovative approach utilizes chimeric antigen receptor T-cells (CARs), which are engineered immune cells designed to overcome immune evasion by targeting and eliminating tumor cells that express specific antigens. While existing CAR therapies have shown promise in treating liquid tumors such as acute lymphoblastic leukemia and lymphoma, challenges remain in addressing solid tumors, managing toxicities, and ensuring long-lasting effectiveness. Chimera Bioengineering addresses these limitations by incorporating drug-responsive gene regulators that enhance CAR functionality. This strategy aims to minimize adverse effects, improve therapeutic efficacy, and extend the persistence of CARs, ultimately striving for more effective and sustainable cures for cancer patients, particularly those who have not responded to traditional therapies.

Sonoma Orthopedic Products

Venture Round in 2016
Sonoma Orthopedics specializes in the design and development of proprietary orthopedic implants aimed at addressing complex fractures. Utilizing the WaviBody technology platform, the company provides quick and minimally invasive surgical solutions tailored for active patients. Their focus is on fracture fixation devices that enable orthopedic surgeons to effectively repair challenging bone geometries. By offering operative treatments that facilitate faster recovery, Sonoma Orthopedics aims to help patients return to work and their daily activities sooner.

Glue Networks

Venture Round in 2016
Glue Networks specializes in providing an enterprise-grade cloud networking service. Glue Virtual Office is available to enterprise customers through partnerships between Glue Networks and top service providers and value-added resellers. It was founded in 2007 and headquartered in Sacramento, California.

The Detection Group

Venture Round in 2016
The Detection Group, Inc. is a technology company that specializes in monitoring and alarming solutions aimed at preventing water damage in various properties, including commercial and residential buildings, retail stores, and medical facilities across the United States. Established in 2006 and headquartered in Palo Alto, California, the company initially emerged from a need identified by its founders, who had experience in the remediation business. The Detection Group offers a web-based automatic leak detection system that operates 24/7, significantly mitigating risks associated with water leaks, such as damage, lost productivity, and health issues related to mold. The system continuously monitors potential leak sources, triggers local alarms during water events, and notifies designated contacts while also tracking response times for insurance purposes. The company's solutions cater to commercial property managers, residential multi-story property managers, and insurance providers, and are distributed through dealers located in several states, including Maryland, New Jersey, New York, California, and Massachusetts.

SupportPay

Venture Round in 2016
Ittavi, Inc was the original creator of SupportPay, a payment platform designed to assist single, divorced, separated, and blended families in managing their financial relationships. The platform enabled users to track child support payments and share expenses directly between parents, facilitating the management of financial obligations. Features included expense tracking, receipt storage, and payment processing. However, Ittavi, Inc was liquidated in early 2018 and no longer exists. The assets and operations of SupportPay were subsequently acquired by Smart Family Tech, Inc, which now oversees the platform and its services.

RenovoRx

Series C in 2015
RenovoRx, Inc. is a medical device company based in Los Altos, California, established in 2012. It focuses on developing innovative solutions for the targeted delivery of therapeutic and diagnostic agents to specific sites within the peripheral vascular system. The company's flagship product, the RenovoCath, is designed for use in the visceral and peripheral vascular systems and has received FDA clearance for clinical use. RenovoRx aims to enhance therapeutic outcomes for cancer patients through its proprietary Trans-Arterial Micro-Perfusion therapy platform, which allows for precise delivery of treatments directly to tumors while potentially reducing systemic side effects. The company is supported by a dedicated management team and an advisory board composed of experts in interventional radiology, surgical oncology, and gastroenterology, providing guidance for its clinical development strategies.

DecisionNext

Seed Round in 2015
DecisionNext, Inc. is a provider of a cloud-based predictive analytics platform tailored for commodities-driven businesses, including sectors such as minerals, agribusiness, fishing, forestry, oil, and gas. Established in 2013 and headquartered in San Francisco, California, with an additional office in Brisbane, Australia, the company focuses on enhancing decision-making processes for its clients. The platform offers a range of solutions, including commodity price forecasting, purchasing optimization, product mix optimization, capacity optimization, and pricing and promotion optimization. By integrating these functionalities into a unified system, DecisionNext enables clients to improve end-to-end performance, maximize profit margins, and reduce uncertainty through real-time validation of forecasting models and simulation of market scenarios.

Zephyrus Biosciences

Seed Round in 2014
Zephyrus Biosciences, Inc. is a life science research tools company based in Berkeley, California, founded in 2013. The company specializes in the development and commercialization of innovative research tools that facilitate protein analysis at the single-cell level. Its flagship product, the scWestern System, allows for western blotting on individual cells, a significant advancement in the field of single-cell analysis. This system employs microfluidics technology to isolate single cells in micro-wells, lysing them and performing SDS-PAGE separation on each lysate. Researchers utilize Zephyrus's tools to explore critical areas such as cancer biology, stem cell research, neurology, and broader human disease studies, ultimately contributing to advancements in diagnostics and therapeutics. As of March 2016, Zephyrus operates as a subsidiary of Bio-Techne Corp.

Gemmus Pharma

Series B in 2014
Gemmus Pharma Inc. is a biotechnology company based in San Francisco, California, founded in 2007. The company focuses on developing therapeutics for the treatment of influenza and other infectious diseases. Its lead candidates include GP1001, a non-peptidic eicosanoid analog designed for serious influenza infections that may require hospitalization, and GP1681, which aims to alleviate influenza symptoms by reducing the exaggerated cytokine response induced by the virus. GP1001 can be used as a stand-alone treatment or in combination with antiviral drugs such as oseltamivir. Gemmus Pharma has received support from the National Institute of Allergy and Infectious Disease and has plans to file an investigational new drug application with the FDA to advance its influenza treatment initiatives.

RenovoRx

Series B in 2014
RenovoRx, Inc. is a medical device company based in Los Altos, California, established in 2012. It focuses on developing innovative solutions for the targeted delivery of therapeutic and diagnostic agents to specific sites within the peripheral vascular system. The company's flagship product, the RenovoCath, is designed for use in the visceral and peripheral vascular systems and has received FDA clearance for clinical use. RenovoRx aims to enhance therapeutic outcomes for cancer patients through its proprietary Trans-Arterial Micro-Perfusion therapy platform, which allows for precise delivery of treatments directly to tumors while potentially reducing systemic side effects. The company is supported by a dedicated management team and an advisory board composed of experts in interventional radiology, surgical oncology, and gastroenterology, providing guidance for its clinical development strategies.

Scopix

Series A in 2012
Scopix is a leader in intelligent video analytics tailored for retailers, consumer packaged goods companies, and manufacturers. The company offers a cloud-based platform that delivers actionable insights through its Real.Suite™ family of solutions. This platform collects data on key performance indicators such as store personnel effectiveness, customer feedback, and queue lengths, which are essential for enhancing retail operations. By providing timely information via a web-based portal, Scopix enables store personnel, regional managers, and corporate executives to optimize the customer experience and improve overall business performance, ultimately driving sales and maximizing profits.

Intrapace

Venture Round in 2012
IntraPace, Inc. specializes in the development and marketing of implantable devices aimed at treating obesity. Founded in 2001 and located in Mountain View, California, the company has created the abiliti system, which stimulates a satiety response to facilitate weight loss. This innovative device is based on technology commonly used in cardiac pacemakers and defibrillators, allowing for implantation through standard laparoscopic methods. Notably, the abiliti system does not alter the digestive system's anatomy and imposes no restrictions on a patient's dietary intake, making it a versatile option for individuals seeking weight management solutions.

Gemmus Pharma

Series A in 2012
Gemmus Pharma Inc. is a biotechnology company based in San Francisco, California, founded in 2007. The company focuses on developing therapeutics for the treatment of influenza and other infectious diseases. Its lead candidates include GP1001, a non-peptidic eicosanoid analog designed for serious influenza infections that may require hospitalization, and GP1681, which aims to alleviate influenza symptoms by reducing the exaggerated cytokine response induced by the virus. GP1001 can be used as a stand-alone treatment or in combination with antiviral drugs such as oseltamivir. Gemmus Pharma has received support from the National Institute of Allergy and Infectious Disease and has plans to file an investigational new drug application with the FDA to advance its influenza treatment initiatives.

Turpitude

Series A in 2011
Turpitude provides clients, including developers, publishers and property holders, with AAA game design consulting services along with creating games as well.

OncoHealth

Series A in 2011
OncoHealth is a company that specializes in creating screening devices aimed at the detection and diagnosis of cancer. The primary focus of its devices is the development of protein bio-markers, which are essential for the screening and diagnostic processes related to cervical cancer and other cancers associated with human papillomavirus (HPV). By advancing these technologies, OncoHealth enables medical professionals to effectively monitor, diagnose, and treat cancer, thereby contributing to improved patient outcomes in oncology.

Taulia

Series A in 2010
Taulia Inc. is a technology company that specializes in artificial intelligence-based supply chain management and financing solutions. Founded in 2009 and headquartered in San Francisco, California, Taulia offers a comprehensive platform designed to enhance working capital management for businesses. Its services include dynamic discounting, supply chain finance, cash forecasting, invoice automation, and supplier management. The platform enables companies to convert invoices into revenue opportunities by facilitating early payments through both internal and third-party funding. Additionally, Taulia's solutions support electronic invoicing by accommodating all formats without imposing fees on suppliers, thus promoting wider participation. The company also empowers suppliers with self-service tools, allowing them to manage their invoicing and financing needs independently. Taulia has established a strategic partnership with KPMG and maintains offices in various locations, including Salt Lake City, Austin, New Orleans, London, Dusseldorf, Sofia, and Sydney.

Qumu

Debt Financing in 2010
Qumu Corporation specializes in providing comprehensive tools for enterprises to create, manage, secure, distribute, and measure live and on-demand video content. The company offers an end-to-end solution that includes software licenses, server appliances, software-enabled devices, and a cloud-hosted software-as-a-service platform. In addition to these products, Qumu provides maintenance, support, and professional services. Its solutions cater to a variety of sectors, including banking, finance, insurance, manufacturing, telecom, technology, and healthcare, as well as government entities, through both direct sales and partnerships. Founded in 1978 and headquartered in Minneapolis, Minnesota, Qumu was formerly known as Rimage Corporation before rebranding in 2013. The majority of the company's revenue is generated from North America, with additional markets in Europe and Asia.

Bella Pictures

Debt Financing in 2009
Bella Pictures is a wedding photography company that offers affordable and high-quality photography and videography services. Founded in 2003 and headquartered in San Francisco, California, the company specializes in capturing memorable moments at weddings through a range of packages. Bella Pictures provides expert advice, a variety of album options, and additional services to enhance the overall experience for couples. The company's innovative approach aims to deliver exceptional photography tailored to individual needs, making it a notable choice for those planning their special day.

Qumu

Series C in 2008
Qumu Corporation specializes in providing comprehensive tools for enterprises to create, manage, secure, distribute, and measure live and on-demand video content. The company offers an end-to-end solution that includes software licenses, server appliances, software-enabled devices, and a cloud-hosted software-as-a-service platform. In addition to these products, Qumu provides maintenance, support, and professional services. Its solutions cater to a variety of sectors, including banking, finance, insurance, manufacturing, telecom, technology, and healthcare, as well as government entities, through both direct sales and partnerships. Founded in 1978 and headquartered in Minneapolis, Minnesota, Qumu was formerly known as Rimage Corporation before rebranding in 2013. The majority of the company's revenue is generated from North America, with additional markets in Europe and Asia.

MOG

Series C in 2008
MOG Inc. is a music media company established in June 2005, aimed at enhancing the music listening experience. It offers an on-demand streaming service that grants users access to a vast library of over 14 million songs from more than a million albums. This service is available across multiple platforms, including mobile apps for iPhone and Android, web browsers, and desktop applications for Mac, with plans for Windows integration. MOG's service is noted for its user-friendly interface, strong discovery features, and high audio quality. Additionally, MOG operates The MOG Music Network, a prominent online hub for music content and the largest advertising network focused on music, attracting over 60 million unique visitors monthly across more than 1,500 music-related websites. The company is based in Berkeley, California, and has garnered investment from notable firms including Menlo Ventures and Universal Music Group. Rick Rubin, a renowned record producer, serves on MOG's Board of Directors.

Podaddies

Angel Round in 2007
Podaddies, Inc. is an online video advertising company based in San Francisco, California, specializing in in-stream video advertising technology. Founded in 2006, Podaddies enables marketers to integrate media content into video formats, even post-download, while offering a platform for tracking, targeting, and managing advertising campaigns. Their proprietary technology allows advertisers to insert video ads into content in real time and provides viewer, contextual, and behavioral targeting services. Podaddies serves a diverse clientele that includes content publishers, social networks, podcasters, and video consumers. The company is recognized for its innovative and flexible advertising solutions that help marketers reach targeted audiences effectively across various platforms, including mobile and online video. As a privately-held corporation, Podaddies is supported by experienced investors and continues to enhance its services and technologies to meet the evolving needs of the advertising landscape.

MOG

Series B in 2007
MOG Inc. is a music media company established in June 2005, aimed at enhancing the music listening experience. It offers an on-demand streaming service that grants users access to a vast library of over 14 million songs from more than a million albums. This service is available across multiple platforms, including mobile apps for iPhone and Android, web browsers, and desktop applications for Mac, with plans for Windows integration. MOG's service is noted for its user-friendly interface, strong discovery features, and high audio quality. Additionally, MOG operates The MOG Music Network, a prominent online hub for music content and the largest advertising network focused on music, attracting over 60 million unique visitors monthly across more than 1,500 music-related websites. The company is based in Berkeley, California, and has garnered investment from notable firms including Menlo Ventures and Universal Music Group. Rick Rubin, a renowned record producer, serves on MOG's Board of Directors.

Sonoma Orthopedic Products

Series B in 2007
Sonoma Orthopedics specializes in the design and development of proprietary orthopedic implants aimed at addressing complex fractures. Utilizing the WaviBody technology platform, the company provides quick and minimally invasive surgical solutions tailored for active patients. Their focus is on fracture fixation devices that enable orthopedic surgeons to effectively repair challenging bone geometries. By offering operative treatments that facilitate faster recovery, Sonoma Orthopedics aims to help patients return to work and their daily activities sooner.

Catalist Homes

Series D in 2007
Catalist Homes is a real estate company providing a higher quality of client service through professional personnel working out of local offices and backed with tremendous corporate support. A reduction in fees would be meaningless if your home did not achieve its maximum value on the market. The good news for CataList Home's clients is they not only save thousands of dollars in fees, but yield higher prices and almost identical marketing times than other homes sold in the market. Data from hundreds of CataList sales in Los Angeles and Orange County prove that they achieve the highest sold price to listing price The truth is, it does not cost any real estate agent more than 3% to sell a home. Fees in excess of 3% represent an excessive charge to the home seller for the use of a real estate agent involved in an old, inefficient and costly system. Instead, you should be asking: "How can Realtors continue to charge five and six percent commissions (typically eliminating 20-25% of homeowner equity) when the average home is sold in less than 30 days?" When you consider the fact that home prices have virtually doubled in the last five years, how can Realtors keep the commission percentage the same and essentially double their fee? Your conventional agent is asking you for a 100% pay raise in 5 years, and he wants you to pay for it. A 3% commission in 2006 is the same dollar cost as 6% just five years ago when you factor in home appreciation. This is how they offer all the essential service for 3%.

Sonoma Orthopedic Products

Series A in 2007
Sonoma Orthopedics specializes in the design and development of proprietary orthopedic implants aimed at addressing complex fractures. Utilizing the WaviBody technology platform, the company provides quick and minimally invasive surgical solutions tailored for active patients. Their focus is on fracture fixation devices that enable orthopedic surgeons to effectively repair challenging bone geometries. By offering operative treatments that facilitate faster recovery, Sonoma Orthopedics aims to help patients return to work and their daily activities sooner.

Mobile Content Networks

Series A in 2006
MCN (Mobile Content Networks) provides mobile search management and revenue solutions that connect mobile users directly to the content they seek while delivering profitable new revenue streams for operators and content providers. MCN is led by an experienced, global management team and backed by some of the most successful venture capital firms in the U.S. and Japan. Before launching the company in 2004, MCN conducted a multi-year study of the unique characteristics of the mobile commerce ecosystem. Equipped with a thorough understanding of the industry’s unique needs, MCN pioneered real-time federated search management, as well as the mobile industry’s highest performing paid search program, allwords.

Qumu

Series B in 2006
Qumu Corporation specializes in providing comprehensive tools for enterprises to create, manage, secure, distribute, and measure live and on-demand video content. The company offers an end-to-end solution that includes software licenses, server appliances, software-enabled devices, and a cloud-hosted software-as-a-service platform. In addition to these products, Qumu provides maintenance, support, and professional services. Its solutions cater to a variety of sectors, including banking, finance, insurance, manufacturing, telecom, technology, and healthcare, as well as government entities, through both direct sales and partnerships. Founded in 1978 and headquartered in Minneapolis, Minnesota, Qumu was formerly known as Rimage Corporation before rebranding in 2013. The majority of the company's revenue is generated from North America, with additional markets in Europe and Asia.

MOG

Series A in 2006
MOG Inc. is a music media company established in June 2005, aimed at enhancing the music listening experience. It offers an on-demand streaming service that grants users access to a vast library of over 14 million songs from more than a million albums. This service is available across multiple platforms, including mobile apps for iPhone and Android, web browsers, and desktop applications for Mac, with plans for Windows integration. MOG's service is noted for its user-friendly interface, strong discovery features, and high audio quality. Additionally, MOG operates The MOG Music Network, a prominent online hub for music content and the largest advertising network focused on music, attracting over 60 million unique visitors monthly across more than 1,500 music-related websites. The company is based in Berkeley, California, and has garnered investment from notable firms including Menlo Ventures and Universal Music Group. Rick Rubin, a renowned record producer, serves on MOG's Board of Directors.

Modviz

Seed Round in 2004
Modviz specializes in virtual graphics solutions for data visualization. The company offers software that assists organizations in visualizing large 3D data sets on computing clusters, enhancing their ability to interpret complex information. Additionally, Modviz provides a 3D graphics computing platform that supports data visualization and the development of custom OpenGL applications, catering to a range of industries that require advanced graphical representations of data.

Clairvoyante

Series B in 2004
Clairvoyante develops PenTile RGBW technology to optimize screen brightness, resolution, and power consumption of flat-panel liquid crystal displays that enables high-brightness and low-power displays that needs to support data-centric 3G applications and contents. Clairvoyante is a U.S.-based company that was founded in 2000 by Candice Brown Elliott. The company was acquired by Samsung Electronics on March, 2008.

NeoGuide Systems

Series B in 2003
NeoGuide Systems Inc. is a developer of robotic endoscopic technology specifically designed for natural orifice transluminal endoscopic surgery (NOTES). Founded in 2000 and based in San Jose, California, the company focuses on creating advanced solutions for medical procedures, particularly in colonoscopy applications. Its innovative technology aims to enhance the visualization and delivery of therapies within the body, thereby improving access to abdominal and thoracic cavities. NeoGuide is positioned at the forefront of a transformative approach in minimally invasive surgery, contributing to the evolution of medical practices in the field.

Media Publisher

Series A in 2003
Media Publisher, Inc. (MPI) is the leader in Enterprise Video Communication, enabling Fortune 2000 companies to UNIFY content from a wide array of content providers and file types, CREATE live and on-demand video presentations, MANAGE video assets in a scalable and robust EVC platform, and DELIVER video content to an organization's existing network and computing infrastructure. Media Publisher Solutions offer significant value to the enterprise in Corporate Communications, Sales and Channel Enablement, and Engineering/R&D Distance Learning. Many large-scale, international customers have adopted Media Publisher Solutions to drive significant revenue generation benefits across the enterprise. Additionally, Media Publisher leverages past infrasturucture investments to deliver dramatic efficiency-gain and productivity benefits. Business video delivered via the internet is now a reliable and cost-effective communications tool for the enterprise. Corporate networks, video software applications, and enterprise infrastructure have matured to allow companies to broadcast streaming video presentations cost-effectively and easily without expensive proprietary hardware or satellite networks. Far more compelling than audio or web conferences, broadcast video helps companies communicate more effectively, improve productivity, and cut costs. Media Publisher enterprise software eliminates much of the technical complexity involved in creating, broadcasting and managing business video. Their products help large organizations remove IT as a process bottleneck while allowing IT to maintain control of their infrastructure and enabling even non-technical employees to fully utilize business video publishing and management tools. Enterprise-class and fully deployed and tested in eight of the Fortune 50, Media Publisher 4.0 is helping companies make broadcast video communications over IP a mission critical application.

Qumu

Series A in 2003
Qumu Corporation specializes in providing comprehensive tools for enterprises to create, manage, secure, distribute, and measure live and on-demand video content. The company offers an end-to-end solution that includes software licenses, server appliances, software-enabled devices, and a cloud-hosted software-as-a-service platform. In addition to these products, Qumu provides maintenance, support, and professional services. Its solutions cater to a variety of sectors, including banking, finance, insurance, manufacturing, telecom, technology, and healthcare, as well as government entities, through both direct sales and partnerships. Founded in 1978 and headquartered in Minneapolis, Minnesota, Qumu was formerly known as Rimage Corporation before rebranding in 2013. The majority of the company's revenue is generated from North America, with additional markets in Europe and Asia.

AirPrime

Series B in 2000
The company develops code division multiple access chipsets for wireless voice and data products.

YY Technologies

Venture Round in 2000
YY is the world leader in Natural Language Processing technology, offering software that enables computers to really understand language as people naturally speak or write it. This means that YY software understands: - Full sentences, not just keywords and menu choices - Multiple sentences and multiple topics in the same message - Sentences with incorrect grammar, structure, spelling or punctuation - Either text or voice input YY software translates natural language sentences and paragraphs to detailed XML instructions, thus enabling written or spoken natural language to be the interface to a variety of database and other applications. With YY, automatic machine-generated responses are 99% accurate the first time, are generated within 60 seconds of the input, and include order processing information, embedded links to relevant documents, and other data relevant to responding to the user's need.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.